Financhill
Sell
40

ATNM Quote, Financials, Valuation and Earnings

Last price:
$1.20
Seasonality move :
5.17%
Day range:
$1.18 - $1.30
52-week range:
$1.03 - $10.24
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
0.97x
Volume:
229.1K
Avg. volume:
158.4K
1-year change:
-81.8%
Market cap:
$37.1M
Revenue:
$81K
EPS (TTM):
-$1.39

ATNM Analysts' Consensus Rating

The 3 analysts providing 12-month price projections for Actinium Pharmaceuticals shares anticipate an average target of $5.00, ranging from a low estimate of $2.00 to a high estimate of $9.00. This average target implies a growth of 320.17% compared to the current stock price of $1.19.

Consensus Price Target

$5.00

Highest Price Target

$9.00

Lowest Price Target

$2.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 0 0 2

Hold 0 0 1

Sell 0 0 0
Consensus -- -- Buy

ATNM Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Alphabet Stock No Longer a Good Bet?
Is Alphabet Stock No Longer a Good Bet?

Alphabet tripled its price per share over the past 5…

Pepsi Vs Coke Stock: Which Is Best?
Pepsi Vs Coke Stock: Which Is Best?

Coca-Cola (NYSE:KO) and PepsiCo (NYSE:PEP) are two of the largest…

Is CyberArk The Next Big Cybersecurity Stock?
Is CyberArk The Next Big Cybersecurity Stock?

CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…

Stock Ideas

Buy
52
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Sell
48
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Buy
52
RGC alert for Mar 19

Regencell Bioscience Holdings [RGC] is down 0.66% over the past day.

Sell
49
SRPT alert for Mar 19

Sarepta Therapeutics [SRPT] is up 8.72% over the past day.

Sell
46
CVNA alert for Mar 19

Carvana [CVNA] is up 5.74% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock